SELLAS Life Sciences Group, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€26.64M -17.3% N/A -€30.54M +36.6% N/A
    €0.00 -100.0% -€32.21M -9.6% N/A -€22.35M +34.2% N/A
    €862.59K -86.8% -€35.63M +99.5% -4,130.1% -39 pp -€16.66M -25.8% -1,930.9% -16 pp
    €6.56M +300.0% -€17.85M +23.5% -272.4% +6.1 pp -€22.45M +149.8% -342.4% +2.1 pp
    €1.64M +∞% -€14.45M -13.1% -881.9% -8.8 pp -€8.99M -41.0% -548.3% -5.5 pp
    €0.00 +NaN% -€16.64M -30.3% N/A -€15.22M -42.0% N/A
    €0.00 +NaN% -€23.87M +16.5% N/A -€26.24M +176.8% N/A
    €0.00 +NaN% -€20.49M +0.9% N/A -€9.48M -75.5% N/A
    €0.00 +NaN% -€20.31M -63.1% N/A -€38.74M -6.5% N/A
    €0.00 -100.0% -€55.12M +74.6% N/A -€41.41M +28.6% N/A
    €8.04M +274.7% -€31.58M -52.3% -392.8% +27 pp -€32.21M +185.9% -400.7% +1.2 pp
    €2.15M +22.0% -€66.14M +119.3% -3,083.2% -14 pp -€11.27M -37.7% -525.1% +5.0 pp
    €1.76M +∞% -€30.16M +204.5% -1,715.8% -17 pp -€18.08M +43.4% -1,028.6% -10 pp
    €0.00 +NaN% -€9.91M -4.2% N/A -€12.61M +44.0% N/A
    €0.00 +NaN% -€10.35M -34.8% N/A -€8.76M -13.1% N/A
    €0.00 +NaN% -€15.86M +27.9% N/A -€10.08M +26.2% N/A
    €0.00 +NaN% -€12.40M +30.8% N/A -€7.99M +59.2% N/A
    €0.00 +NaN% -€9.48M +357.0% N/A -€5.02M +175.5% N/A
    €0.00 -€2.07M N/A -€1.82M N/A

    Notifications